Patents/Assignees

SOVARGEN CO., Ltd.

2 patents in portfolio

US12570975utility2026
Composition for Diagnosis or Treatment of a Condition Associated with Increased Activity of EIF4E Comprising an EIF4E Inhibitor
0 cites
US12453733utility2025
Composition for Prevention or Treatment of Intractable Epilepsy Comprising Mtor Inhibitor
0 cites